Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Co-induction agents and cardiac output during propofol anesthesia induction
ACTRN12610000447055Phase 4Completed
- Sponsor
- Christchurch Anaesthesia Education Trust
- Start
- Nov 2009
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of propofol, midazolam and fentanyl in Biliopancreatic neoplasm (4 arms), sponsored by Christchurch Anaesthesia Education Trust. Primary endpoints: Propofol amount required to loss of consciousness by syringe drop, Propofol amount required to loss of consciousness by lack of response to command and 2 more. Started Nov 2009; status: completed.
02
Drugs
propofolmidazolamfentanyl
03
Conditions
Biliopancreatic neoplasm
Beyond the preview
Go deeper on ACTRN12610000447055.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12610000447055.